Skip to main content
Sanjeev M. Raman
( out of 66 reviews )

Sanjeev M. Raman, MBBS, MD

Languages spoken: English, Hindi, Konkani, Marathi, Tamil, French

Clinical Locations

Transplant Center

Transplant Center
Salt Lake City
801-585-3697
  • Sanjeev M. Raman, MD is an Associate Professor of Medicine in the Pulmonary Division, University of Utah School of Medicine. He has been a faculty member in the Pulmonary Division since 2009, when was recruited to the University of Utah to expand its Lung Transplant Program.

    Dr. Raman specializes in the evaluation and care of patients with advanced lung diseases and focuses most of his clinical and research effort on lung transplant recipients.

    His other clinical and research interests include emphysema/ chronic obstructive pulmonary disease (COPD), and he is the primary bronchoscopist and co-investigator for the University of Utah Clinical Center for SPIROMICS ( SubPopulations And InteRmediate Outcome Measures In COPD Study). SPIROMICS is a multi-center study funded by the National Heart, Lung, and Blood Institute (NHLBI) and the COPD Foundation, and supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. Since 2009, it has enrolled approximately 3200 patients across the U.S.

    Dr. Raman is an attending physician at the University of Utah Hospitals and Clinics and provides care to patients on the Pulmonary Medicine inpatient service, the Pulmonary Consult service, as well as the Medical Intensive Care Unit. He is also the Medical Director of the Pulmonology inpatient service, and the "pulmonary ward", where he is involved in quality improvement and safety measures.



    In addition to his clinical activities, he is actively involved in the teaching and training of University of Utah Fellows, Residents, and medical students.

    Dr. Raman was born and raised in Mumbai (formerly Bombay), India, and attended medical school at Grant Medical College & Sir J.J. Group of Hospitals. He subsequently received his medical degree from the University of Mumbai in Mumbai, India. He completed his residency in Internal Medicine at Michigan State University/ Kalamazoo Center for Medical Studies in Kalamazoo, Michigan. He then underwent fellowship training in Pulmonary and Critical Care Medicine at Baylor College of Medicine in Houston, Texas, and at the lung transplant program at The Methodist Hospital, Houston.

    He is Board Certified in the subspecialties of Pulmonary and Critical Care Medicine, as well as Internal Medicine. He is also certified by the Educational Commission For Foreign Medical Graduates (ECFMG).

    In his free time, he enjoys reading, photography, and exploring the musical and guitaristic stylings of David Gilmour in a SLC-based Pink Floyd tribute band called "Quiet Desperation".

    Board Certification

    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    4.9 /5
    ( out of 66 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    March 31, 2025
    UNIVERSITY HOSPITAL

    Dr Raman is cool taking the time to explain all the options

    March 27, 2025
    UNIVERSITY HOSPITAL

    He was very friendly, very professional and as always make sure you understand what's going on

    March 23, 2025
    UNIVERSITY HOSPITAL

    About 5yrs ago, Dr Raman gave me all the info ( good and bad) on lung transplant surgery for which I was very grateful. I needed to hear all that to help make my decision. Obviously, I went ahead with the surgery and didn't look back. Dr. Raman has been part of my post surgery care since that day and continues to give me all information in a way I can understand and answers any questions I have with the truth.

    February 18, 2025
    UNIVERSITY HOSPITAL

    Very enjoyable. Your Institute is very lucky to have him

    February 15, 2025
    UNIVERSITY HOSPITAL

    Dr. Raman is very knowledgeable and is very personable.

    February 03, 2025
    UNIVERSITY HOSPITAL

    Very knowledgeable and helpful.

    December 20, 2024
    UH HOSPITALS AND CLINICS

    Dr. Raman is very thorough and great at explaining the complicated.

    December 19, 2024
    UH HOSPITALS AND CLINICS

    Your hospital should be very proud to have Dr Raman on your staff.

    November 29, 2024
    UH HOSPITALS AND CLINICS

    I am doctor Sanjeev Raman biggest promoter he was the first person I spoke to about my transplant and he has been very good throughout the process please thank him

  • Sanjeev M. Raman, MD is an Associate Professor of Medicine in the Pulmonary Division, University of Utah School of Medicine. He has been a faculty member in the Pulmonary Division since 2009, when was recruited to the University of Utah to expand its Lung Transplant Program.

    Dr. Raman specializes in the evaluation and care of patients with advanced lung diseases and focuses most of his clinical and research effort on lung transplant recipients.

    His other clinical and research interests include emphysema/ chronic obstructive pulmonary disease (COPD), and he is the primary bronchoscopist and co-investigator for the University of Utah Clinical Center for SPIROMICS ( SubPopulations And InteRmediate Outcome Measures In COPD Study). SPIROMICS is a multi-center study funded by the National Heart, Lung, and Blood Institute (NHLBI) and the COPD Foundation, and supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. Since 2009, it has enrolled approximately 3200 patients across the U.S.

    Dr. Raman is an attending physician at the University of Utah Hospitals and Clinics and provides care to patients on the Pulmonary Medicine inpatient service, the Pulmonary Consult service, as well as the Medical Intensive Care Unit. He is also the Medical Director of the Pulmonology inpatient service, and the "pulmonary ward", where he is involved in quality improvement and safety measures.



    In addition to his clinical activities, he is actively involved in the teaching and training of University of Utah Fellows, Residents, and medical students.

    Dr. Raman was born and raised in Mumbai (formerly Bombay), India, and attended medical school at Grant Medical College & Sir J.J. Group of Hospitals. He subsequently received his medical degree from the University of Mumbai in Mumbai, India. He completed his residency in Internal Medicine at Michigan State University/ Kalamazoo Center for Medical Studies in Kalamazoo, Michigan. He then underwent fellowship training in Pulmonary and Critical Care Medicine at Baylor College of Medicine in Houston, Texas, and at the lung transplant program at The Methodist Hospital, Houston.

    He is Board Certified in the subspecialties of Pulmonary and Critical Care Medicine, as well as Internal Medicine. He is also certified by the Educational Commission For Foreign Medical Graduates (ECFMG).

    In his free time, he enjoys reading, photography, and exploring the musical and guitaristic stylings of David Gilmour in a SLC-based Pink Floyd tribute band called "Quiet Desperation".

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary/Critical Care - Baylor College of Medicine Fellow
    Chief Resident Internal Medicine - Michigan State University Chief Resident
    Residency Internal Medicine - Michigan State University Resident
    Internship Internal Medicine - Michigan State University Intern
    Professional Medical Medical School - Grant Medical College M.B.B.S.
    Professional Medical Medical School - University of Mumbai, Dr. D.Y. Patil Medical College M.B.B.S.
    Undergraduate R. N Ruia College of Arts & Science Higher Secondary Certificate

    Selected Publications

    Journal Article

    1. Opron K, Begley LA, Erb-Downward JR, Li G, Alexis NE, Barjaktarevic I, Barr RG, Bleecker ER, Boucher R, Bowler RP, Christenson SA, Comellas AP, Criner G, Cooper CB, Couper D, Galban CJ, Han MK, Hastie A, Hatt C, Hoffman EA, Kaner RJ, Kesimer M, Krishnan JA, LaFon DC, Martinez FJ, Ortega VE, Peters SP, Paine R 3rd, Putcha N, Woodruff PG, Huffnagle GB, Kozik AJ, Curtis JL, Huang YJ, SPIROMICS Investigators (2025). Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 210(2), 186-200. (Read full article)
    2. Gerard SE, Dougherty TM, Nagpal P, Jin D, Han MK, Newell JD Jr, Saha PK, Comellas AP, Cooper CB, Couper D, Fortis S, Guo J, Hansel NN, Kanner RE, Kazeroni EA, Martinez FJ, Motahari A, Paine R 3rd, Rennard S, Schroeder JD, Woodruff PG, Barr RG, Smith BM, Hoffman EA, SPIROMICS Research Group (2025). Vessel and Airway Characteristics in One-Year Computed Tomography-defined Rapid Emphysema Progression: SPIROMICS. Ann Am Thorac Soc, 21(7), 1022-1033. (Read full article)
    3. Kagawa H, Stringham J, Selzman C, Goodwin M, Frye L, Raman S, Cahill B, Morrell M (2023). Case Report of Needle Disruption of the Retroperitoneal Lymph Nodes for Refractory Chylothorax After Double Lung Transplantation. Transplant Proc, 55(8), 1981-1983. (Read full article)
    4. Motahari A, Barr RG, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN, Kanner RE, Kazerooni EA, Lynch DA, Martinez FJ, Newell JD Jr, Schroeder JD, Smith BM, Woodruff PG, Hoffman EA, SPIROMICS Group (2023). Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 208(6), 657-665. (Read full article)
    5. Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R 3rd, Kanner RE, Curtis JL, Bowler RP, Martinez FJ, Hansel NN, Krishnan JA, Woodruff PG, Barjaktarevic IZ, Couper D, Anderson WH, Cooper CB, Subpopulations and Intermediate Outcome Measures in COPD Study Investigators (2022). Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest, 163(3), 502-514. (Read full article)
    6. Buhr RG, Barjaktarevic IZ, Quibrera PM, Bateman LA, Bleecker ER, Couper DJ, Curtis JL, Dolezal BA, Han MK, Hansel NN, Krishnan JA, Martinez FJ, McKleroy W, Paine R 3rd, Rennard SI, Tashkin DP, Woodruff PG, Kanner RE, Cooper CB, SPIROMICS Investigators (2022). Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med, 206(5), 554-562. (Read full article)
    7. Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper DJ, Cooper CB, Freeman CM, Han MK, Kaner RJ, Labaki W, Martinez FJ, Ortega VE, Peters SP, Paine R, Woodruff P, Curtis JL, Huffnagle GB, Stringer KA, Bowler RP, Esther CR Jr, Reisdorph N, Huang YJ, SPIROMICS Research Group (2022). Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 206(4), 427-439. (Read full article)
    8. Esther CR Jr, ONeal WK, Anderson WH, Kesimer M, Ceppe A, Doerschuk CM, Alexis NE, Hastie AT, Barr RG, Bowler RP, Wells JM, Oelsner EC, Comellas AP, Tesfaigzi Y, Kim V, Paulin LM, Cooper CB, Han MK, Huang YJ, Labaki WW, Curtis JL, Boucher RC, Subpopulations and Intermediate Outcome Measures in COPD Study (2021). Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD. Chest, 161(5), 1239-1249. (Read full article)
    9. OToole J, Woo H, Putcha N, Cooper CB, Woodruff P, Kanner RE, Paine R, Bowler RP, Comellas A, Hoth KF, Krishnan JA, Han M, Dransfield M, Iyer AS, Couper D, Peters SP, Criner G, Kim V, Barr RG, Martinez FJ, Hansel NN, Eakin MN, SPIROMICS Investigators (2021). Comparative Impact of Depressive Symptoms and FEV(1)% on Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 19(2), 171-178. (Read full article)
    10. Marczin N, De Waal EEC et al (2021). International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant, 40(11), 1327-1348.
    11. Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O (2021). ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant, 40(11), 1267-1278. (Read full article)
    12. Qadir N, Bartz RR, Cooter ML, Hough CL, Lanspa MJ, Banner-Goodspeed VM, Chen JT, Giovanni S, Gomaa D, Sjoding MW, Hajizadeh N, Komisarow J, Duggal A, Khanna AK, Kashyap R, Khan A, Chang SY, Tonna JE, Anderson HL 3rd, Liebler JM, Mosier JM, Morris PE, Genthon A, Louh IK, Tidswell M, Stephens RS, Esper AM, Dries DJ, Martinez A, Schreyer KE, Bender W, Tiwari A, Guru PK, Hanna S, Gong MN, Park PK, Severe ARDS Generating Evidence SAGE Study Investigators, Society of Critical Care Medicines Discovery Network (2021). Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study. Chest, 160(4), 1304-1315. (Read full article)
    13. Kasela S, Ortega VE, Martorella M, Garudadri S, Nguyen J, Ampleford E, Pasanen A, Nerella S, Buschur KL, Barjaktarevic IZ, Barr RG, Bleecker ER, Bowler RP, Comellas AP, Cooper CB, Couper DJ, Criner GJ, Curtis JL, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Krishnan JA, Martinez FJ, McDonald MN, Meyers DA, Paine R 3rd, Peters SP, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Israel E, Jarjour NN, Levy BD, Li X, Moore WC, Wenzel SE, Zein J, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study SPIROMICS, NHLBI Trans-Omics for Precision Medicine TOPMed Consortium, Langelier C, Woodruff PG, Lappalainen T, Christenson SA (2021). Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome Med, 13(1), 66. (Read full article)
    14. Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176. (Read full article)
    15. Martinu T, Koutsokera A, Benden C, Cantu E, Chambers D, Cypel M, Edelman J, Emtiazjoo A, Fisher AJ, Greenland JR, Hayes D Jr, Hwang D, Keller BC, Lease ED, Perch M, Sato M, Todd JL, Verleden S, von der Thsen J, Weigt SS, Keshavjee S, bronchoalveolar lavage standardization workgroup (2020). International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. J Heart Lung Transplant, 39(11), 1171-1190. (Read full article)
    16. Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise RA, Brown TT, Drummond MB, SPIROMICS Investigators (2020). Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest, 157(4), 856-865. (Read full article)
    17. Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER, NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study SPIROMICS (2019). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med, 201(5), 540-554. (Read full article)
    18. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou TG (2018). Longer Life or More Life: Choose One Please. J Surg Res, 237, 126-128. (Read full article)
    19. Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, OBeirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL (2019). Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy. Ann Am Thorac Soc, 16(4), 439-446. (Read full article)
    20. Fawzy A, Putcha N, Paulin LM, Aaron CP, Labaki WW, Han MK, Wise RA, Kanner RE, Bowler RP, Barr RG, Hansel NN, SPIROMICS and COPDGene Investigators (2018). Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. Respir Res, 19(1), 20. (Read full article)
    21. McKellar SH, Bowen ME, Baird BC, Raman S, Cahill BC, Selzman CH (2016). Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant. J Heart Lung Transplant, 35(11), 1289-1294. (Read full article)
    22. Wood DE, Nader DA, Springmeyer SC, Elstad MR, Coxson HO, Chan A, Rai NS, Mularski RA, Cooper CB, Wise RA, Jones PW, Mehta AC, Gonzalez X, Sterman DH, IBV Valve Trial Research Team (2014). The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol, 21(4), 288-97. (Read full article)
    23. Couper D1, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S SPIROMICS Research Group Collaborators Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, ONeal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA (2014). Title: Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Authors: Couper D(1), LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S; SPIROMICS Research Group. Collaborators: Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, O'Neal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA. Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD) designed to guide future development of therapies for COPD by providing robust criteria for subclassifying COPD participants into groups most likely to benefit from a given therapy during a clinical trial, and identifying biomarkers/phenotypes that can be used as intermediate outcomes to reliably predict clinical benefit during therapeutic trials. The goal is to enrol 3200 participants in four strata. Participants undergo a baseline visit and three annual follow-up examinations, with quarterly telephone calls. Adjudication of exacerbations and mortality will be undertaken. DOI: 10.1136/thoraxjnl-2013-203897 PMID: 24029743  [Indexed for MEDLINE]. Thorax.

    Review

    1. Liou, T G, Raman, S M, Cahill, B C (2013). Liou, T. G., Raman, S. M., & Cahill, B. C. (2013). Lung transplantation for chronic obstructive pulmonary disease. Transplant Research and Risk Management, 5, 1–20. https://doi.org/10.2147/TRRM.S10765. [Review]. Transpl Res Risk Manag, 5, 1-20.

    Book Chapter

    1. Raman SM, Morrell MR (2017). Respiratory Conditions: Dyspnea. In Sole A, Silveira F (Eds.), ISHLT Monograph Series, Volume 10: What to do in case of...A reference Diagnostic Guide in Thoracic Organ Transplantation: Practical Approach to Frequent Scenarios. Addison, TX: International Society for Heart and Lung Transplantation.

    Conference Proceedings

    1. Mckellar SH, Baird BC, Bowen M, Raman SM, Cahill B, Selzman CH (April 2015). Prior Coronary Artery Bypass Surgery- Is It Still a Contraindication for Lung Transplantation? International Society for Heart and Lung Transplantation35th Annual Meeting and Scientifi c Sessions, Nice, France: The Journal of Heart and Lung Transplantation, 34(4), S134.
    2. Raman SM, Bannon SF (2004). Cellulitis, bacteremia & multiple brain infarctions caused by Erysipelothrix rhusiopathiae: An unusual etiologic agent & its implications on choice of antibiotic therapy. Kalamazoo Community Medical and Health Sciences Research Day, Kalamazoo.

    Editorial

    1. Cahill BC, Raman SM, Selzman CH, Liou TG (2013). Use of older donors for lung transplantation-you can't get there from here. J Heart Lung Transplant, 32(8), 757-9. (Read full article)
    2. Raman SM, Cahill BC (2011). Lung transplantation in older adults: how old is too old? J Heart Lung Transplant, 30(3), 270-2. (Read full article)

    Letter

    1. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. [Letter to the editor]. N Engl J Med, 381(15), 1488-1489. (Read full article)

    Abstract

    1. Cahill BC, Liou TG, Peterson-Short K, Maughan T, Doidge W, Sirandas B, Carlson A, Truax C, Cotiguala L, Raman S, McKellar SH, Selzman CH (April 2017). Post-Lung Transplant Survival After Venous Thromboembolism [Abstract]. ISHLT 37th Annual Meeting and Scientific Sessions, 36(4), S403.